Schlosser Mario sold $217K of OSCR
Schlosser Mario sold 9,668 shares of Oscar Health, Inc. (OSCR) at $22.45 ($0.22M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Traders may treat this as a sentiment/positioning datapoint rather than a fundamental catalyst, especially since it is pre-arranged.
Market read
A disclosed insider sale can create short-lived headline pressure, but 10b5-1 framing usually limits interpretive impact.
What to watch
The filing does not indicate whether additional sales/buys occurred around the same period, nor does it reveal the director’s broader net position changes over time.
Background
SEC Form 4 reports an insider transaction by a director of Oscar Health; the sale was executed under a Rule 10b5-1 plan.
Ticker impact
Oscar Health director Mario Schlosser sold 9,668 shares in an open-market transaction under a pre-arranged 10b5-1 plan.
Low-to-moderate near-term negative bias possible, but unlikely to drive a sustained move absent other catalysts.
The filing provides a concrete sale size and timing, yet explicitly notes a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal; this is company-specific insider activity rather than a sector/regulatory change.
None expected beyond typical single-name sentiment/flow effects.
None expected.
Counterpoint
Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider sale disclosure.
- insiderMario Schlosser
Director who sold 9,668 shares on 2026-06-02.
